15h
Zacks.com on MSNGILD vs. VRTX: Which Stock Is the Better Value Option?But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an ...
8h
Zacks.com on MSNWhy the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained TodayVertex Pharmaceuticals (VRTX) concluded the recent trading session at $502.92, signifying a +1.51% move from its prior day's close.
Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 5 years ago, it would be worth $253.80 today based on a ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
9h
Investor's Business Daily on MSNDow Jones Tumbles 537 Points On Trump Tariff Threats; S&P 500 Enters CorrectionThe Dow Jones Industrial Average tumbled 537 points Thursday as Wall Street reacted to tariff threats from President Trump.
3h
Investor's Business Daily on MSNDow Jones Futures: S&P 500 Hits New Low On Trump Tariff Threats; Warren Buffett Stock Makes Bullish MoveDow Jones futures rose overnight, along with S&P 500 futures and Nasdaq futures, as Senate Democrats signaled they won't block a vote on a GOP spending bill, making a U.S. government shutdown unlikely ...
CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...
Major indices closed lower on Thursday as market participants digested yet another key inflation reading and new tariff ...
Major indices were in the red early on Thursday as market participants digested yet another key inflation reading and new ...
This was the stock's second consecutive day of gains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results